10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 10-Q/A

Amendment No.1

____________

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File Number 000-53878

TECHNOLOGY APPLICATIONS INTERNATIONAL CORPORATION

(Name of small business issuer in its charter)

Florida	27-1116025
(State of incorporation)	(I.R.S. Employer Identification No.)

18851 N.E. 29^th Avenue, Suite 700, Adventura, Florida 33180

(Address of principal executive offices)

(786) 787-0402

(Registrant’s telephone number)

Copy of all Communications to:

Law Office of Andrew Coldicutt

1220 Rosecrans Street, PMB 258

San Diego, CA 92106

Phone: 619-228-4970

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X]   No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [   ]   No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[   ]	Accelerated filer	[   ]
Non-accelerated filer	[   ]. (Do not check if a smaller reporting company)	Smaller reporting company	[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [   ]   No [X]

As of November 10, 2013, there were 117,348,000 shares of the registrant’s $0.001 par value common stock issued and outstanding.

EXPLANATORY NOTE

This Amendment No. 1 (this "Amendment") to the Quarterly Report on Form 10-Q of Technology Applications International Corporation (the "Company") for the quarter ended September 30, 2013, originally filed with the U.S. Securities and Exchange Commission (the "SEC") on November 19, 2013, (the "Original Filing"), is being filed to correct the number of shares outstanding on the cover page of the Original Filing, which number was stated incorrectly as a result of a typographical error, and to include new certifications pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.

Except as described above, this Amendment does not modify or update the disclosures presented in, or exhibits to, the Original Filing in any way.  This Amendment speaks as of the date of the Original Filing and does not reflect events occurring after the filing of the Original Filing.  Accordingly, this Amendment should be read in conjunction with the Original Filing, as well as any other filings made by the Company with the SEC pursuant to Section 13(a) or 15(d) of Securities Exchange Act of 1934, as amended, subsequent to the filing of the Original Filing.

2

ITEM 6. EXHIBITS

Exhibit Number	Description of Exhibit	Filing
3.1	Articles of Incorporation	Filed with the SEC on January 19, 2010 as part of the Company’s Registration of Securities on Form 10-12G.
3.1(a)	Restated Articles of Incorporation	Filed with the SEC on April 18, 2011 as part of the Company’s Current Report on Form 8-K.
3.2	Bylaws	Filed with the SEC on January 19, 2010 as part of the Company’s Registration of Securities on Form 10-12G.
3.2(a)	Amended Bylaws	Filed with the SEC on April 18, 2011 as part of the Company’s Current Report on Form 8-K.
10.1	Lease between Brickell Bay Tower Ltd., Inc. and Raj Ventures, Inc. dated October 18, 2010	Filed with the SEC on March 28, 2010 as part of the Company’s Annual Report on Form 10-K.
10.2	Share Purchase Agreement by and among Raj Ventures, Inc., Willowhuasca Wellness, Inc., and Raj Ventures Funding, Inc., dated April 12, 2010	Filed with the SEC on April 12, 2010 as part of the Company’s Current Report on Form 8-K.
10.3	Bill of Sale and Assignment between Raj Ventures, Inc., and High Voltage Environmental Applications, Inc., dated as of August 26, 2010	Filed with the SEC on September 1, 2010 as part of the Company’s Current Report on Form 8-K.
10.4	Promissory Note between the Company and Joe-Val, Inc., dated March 27, 2012	Filed with the SEC on March 27, 2012 as part of the Company’s Current Report on Form 8-K.
10.5	Promissory Note between the Company and Coast To Coast Equity Group, Inc., dated June 25, 2012	Filed with the SEC on August 20, 2012 as part of the Company’s Quarterly Report on Form 10-Q
10.6	Convertible debenture between the Company and Shane Case, dated September 26, 2012	Filed with the SEC on November 19, 2012 as part of the Company’s Quarterly Report on Form 10-Q
10.7	Distribution Agreement between Regenetech, Inc. and Renuéll Int’l, Inc., dated December 29, 2011 and Amended on December 13, 2012.	Filed with the SEC on January 17, 2013 as part of the Company’s S-1/A.
10.8	Form of Subscription Agreement	Filed with the SEC on November 29, 2012 as part of the Company’s S-1/A.
10.9	Consulting Agreement between the Company and John Stickler	Filed with the SEC on December, 27, 2012 as part of the Company’s S-1/A.
10.10	Co-License Agreement by and between Technology Applications International Corporation and the National Aeronautics and Space Administration, dated September 30, 2013.	Filed with the SEC on October 4, 2013, as part of our Current Report on Form 8-K.
16.1	Letter from Lake and Associates CPA’s LLC, dated March 12, 2013	Filed with the SEC on March 14, 2013 as part of the Company’s Current Report on Form 8-K.
21.1	List of Subsidiaries	Filed with the SEC on April 16, 2012 as part of the Company’s Annual Report on Form 10-K.
31.01	Certification of Principal Executive Officer Pursuant to Rule 13a-14	Filed herewith.
31.02	Certification of Principal Financial Officer Pursuant to Rule 13a-14	Filed herewith.
32.01	Certification of CEO and CFO Pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith.
101.INS*	XBRL Instance Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q
101.SCH*	XBRL Taxonomy Extension Schema Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q.
101.LAB*	XBRL Taxonomy Extension Labels Linkbase Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document	Filed with the SEC on November 19, 2013 as part of the Company’s Quarterly Report on Form 10-Q
*Pursuant to Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

3

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TECHNOLOGY APPLICATIONS INTERNATIONAL CORPORATION

Dated: January 16, 2014

/s/ Charles J. Scimeca

By: Charles J. Scimeca

Its: President, Principal Executive Officer & Principal Financial Officer (Principal Accounting Officer)

Pursuant to the requirement of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated:

Dated: January 16, 2014

/s/ Charles J. Scimeca

Charles J. Scimeca – Director

Dated: January 16, 2014

/s/ John Stickler

John Stickler – Director

4

EX-31.1

Exhibit 31.1 Certification   

EX-31.2

Exhibit 31.2 Certification   

EX-32.1

Exhibit 32.1 Certification   

XML

6. Derivative Liability Fair Value Adjustment (Details) (USD $)						9 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013 Derivative Liability	Dec. 31, 2012 Derivative Liability	Dec. 31, 2011 Derivative Liability	Sep. 30, 2013 Derivative Liability Recorded	Dec. 31, 2012 Derivative Liability Recorded	Sep. 30, 2013 Fair Value Adjustment	Dec. 31, 2012 Fair Value Adjustment
Derivative liability	$ 440,494	$ 276,000	$ 440,949	$ 276,000	$ 0
Derivative liability recorded						399,244	353,200
Fair value adjustment								$ (234,750)	$ (77,200)

XML

4. Convertible Debenture

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements

4. Convertible Debenture

4. Convertible Debenture

During December 2011, the Company received $100,000 as a deposit for entering into a distribution agreement. On March 22, 2012, the Company converted the $100,000 deposit into a convertible debenture. The convertible debenture bears interest at a rate of five-percent (5%) per annum and is payable March 21, 2014. At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share. In

addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share. These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise.

On September 25, 2012, the Company issued a $100,000 convertible debenture. The convertible debenture bears interest at a rate of five-percent (5%) per annum and is payable September 20, 2013. At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share. In addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share. These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise. This convertible debenture extended 360 days on September 21, 2013

On May 23, May 31, June 10, July 29, August 14, and September 25, 2013, the Company issued a $10,000, $10,000, $25,000, $4,000, $50,000 and $20,000 convertible debentures, respectively. The convertible debentures bear interest at a rate of ten-percent (10%) per annum and is payable May 18, May 26, June 5, 2014, July 24, august 9, September 20, 2014, respectively. At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share. In addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share. These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise.

The Compound derivative comprises certain derivative features embedded in the host convertible debenture contracts including the conversion feature and warrants both of which contain anti-dilution protections. These instruments were combined into one compound derivative and bifurcated from the host instrument at fair value. The Company applied the Black-Scholes Merton valuation technique to fair value these derivatives because this technique embodies all of the assumptions necessary to fair value these compound derivative instruments.

Since the derivative financial instruments are required to be recorded, both initially, and subsequently, at fair value, there were insufficient proceeds to allocate any amount to the convertible debentures and, accordingly, it has no carrying value on the date of inception. Additionally, proceeds were insufficient to record the fair values of the derivative financial instruments, resulting in initial interest expense of $283,844. It should be noted that the derivative instruments will be adjusted to fair value at each reporting date. As the Company does not have historical volatility data for its own stock, the expected volatility was based upon the Company’s peer group in the industry in which it does business. Fair values are highly influenced by the trading stock price and volatility of the peer group, changes in our credit risk and market interest rates.

The company amortizes the discount on the convertible debentures resulting from the initial allocation over the term of the convertible debt instruments using the effective method. Amortization expense arising from this method for the nine months ended September 30, 2013 and 2012 was approximately $214,963 and $0, respectively. These amounts have been included as a component of interest expense.

XML

9. Subsequent Events (Details Narrative) (USD $)	Oct. 02, 2013
Subsequent Events [Abstract]
Notes converted to shares of common stock	$ 50,000
Shares of common stock issued from conversion of notes	100,000

XML

3. Machinery and Equipment

9 Months Ended

Sep. 30, 2013

Property, Plant and Equipment [Abstract]

3. Machinery and Equipment

3. Machinery and Equipment

Machinery and equipment are recorded at cost. Expenditures for maintenance and repairs are charged to earnings as incurred whereas additions, renewals and betterments are capitalized. When machinery and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of machinery and equipment is provided using the straight-line method over the assets estimated useful lives of approximately 5 to 7 years. Leasehold improvements, if any, are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

Machinery and equipment, as of September 30, 2013 and December 31, 2012, consisted of the following:

	Estimated Useful Lives	September 30, 2013	December 31, 2012
Computer Equipment	3 Years	$ 4,162	$ 4,162
Machinery and equipment	5 Years	3,418	3,418
Furniture and fixtures	7 Years	14,073	14,073
Accumulated depreciation		(11,170)	(8,191)
		$ 10,483	$ 13,462

Depreciation expense for the nine-month periods ended September 30, 2013 and 2012 were $2,979 and $3,061, respectively. Depreciation expense for the three-month periods ended September 30, 2013 and 2012 were $993 and $1,020, respectively.

XML

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets
Cash and cash equivalents	$ 4,580	$ 120,697
Accounts receivable	0	0
Inventories	121,490	125,408
Deposits	60,000	50,000
Other current assets	1,909	3,814
Total current assets	187,979	299,919
Trademarks, net	1,968	2,049
Machinery and equipment, net	10,483	13,462
Total assets	200,430	315,430
Liabilities
Accounts payable and accrued expenses	313,209	193,894
Advances from affiliate	163,159	157,843
Loan from affiliate	77,401	88,880
Convertible debentures (net of debt discount of $168,973 and $134,292, respectively)	150,027	65,708
Derivative liability	440,494	276,000
Short-term advances	5,000	0
Total current liabilities	1,149,290	782,325
Total liabilities	1,149,290	782,325
Shareholders' deficit
Preferred stock, par value, $0.001 per share, 50,000,000 shares authorized, none issued or outstanding	0	0
Common stock, par value $0.001 par value, 300,000,000 shares authorized, 117,248,000 and 117,248,000 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively.	117,248	117,248
Additional paid in capital	505,220	505,220
Accumulated deficit	(1,571,328)	(1,089,363)
Total shareholders' deficit	(948,860)	(466,895)
Total liabilities and shareholders' deficit	$ 200,430	$ 315,430

XML

1. Nature of Operations and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

1. Nature of Operations and Basis of Presentation

1. Nature of Operations and Basis of Presentation

Nature of Operations

Technology Applications International Corporation (“Technology”) was incorporated on October 14, 2009 under the laws of Florida. Renuell Int’l, Inc. and NueEarth, Inc., Technology’s wholly owned subsidiaries and Technology, collectively, are referred to here-in as the “Company”, a development stage company. The Company is engaged in developing market entry technology products and services into early and mainstream technology products and services. Through our subsidiaries, we are focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology.

Principles of Consolidation

The consolidated financial statements include the accounts of Technology Applications International Corporation and its wholly owned subsidiaries, Renuell Int’l, Inc. and NueEarth, Inc. All significant inter-company accounts and transactions have been eliminated in consolidation.

Basis of Presentation and Going Concern Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2013.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

The accompanying financial statements have been presented on the basis that it is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs. The Company’s ability to continue as a going concern is highly dependent upon management’s ability to increase near-term operating cash flows and obtain additional working capital through the issuance of debt and or equity. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

These consolidated financial statements present the financial condition, and results of operations and cash flows of the operating companies.

Development Stage Risk

Since its inception, the Company has been dependent upon the receipt of capital investment to fund its operating activities. In addition to the normal risks associated with a new business venture, there can be no assurance that the Company’s business plans will be successfully executed. The Company’s ability to execute its business plans is dependent on its ability to obtain additional debt and equity financing and achieving a profitable level of operations. There can be no assurance that sufficient financing will be obtained or that we will achieve a profitable level of operations.

The Company has minimal revenues generated from operations due to the sale of sample products. Accordingly, the Company’s activities have been accounted for as those of a “Development Stage Enterprise” as set forth in Accounting Standards Codification (“ASC”) 915 “Development Stage Entities”. Among the disclosures required are that the Company’s financial statements be identified as those of a development stage company and that the statements of operations, shareholders’ equity / (deficit) and cash flows disclose activity since the date of the Company’s inception.

XML

4. Convertible Debenture (Details Narrative) (USD $)	1 Months Ended	9 Months Ended		47 Months Ended
	Dec. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 25, 2013	Aug. 14, 2013	Jul. 29, 2013	Jun. 10, 2013	May 31, 2013	May 23, 2013	Feb. 13, 2013	Sep. 25, 2012	Mar. 22, 2012	Oct. 28, 2011
Notes to Financial Statements
Deposit on distribution agreeement	$ 100,000
Deposit converted into convertible debenture												100,000
Convertible debenture issued					20,000	50,000	4,000	25,000	10,000	10,000			100,000
Interest rate of convertible debenture, per annum					10.00%	10.00%	10.00%	10.00%	10.00%	10.00%		5.00%	5.00%
Maturity date of convertible debenture					Sep. 20, 2014	Aug. 09, 2014	Jul. 24, 2014	Jun. 05, 2014	May 26, 2014	May 18, 2014		Sep. 20, 2013	Mar. 21, 2014
Debt conversion to common stock rate					$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50		$ 0.50	$ 0.50
Number of warrants offered per share issued from converted debt					1	1	1	1	1	1		1	1
Warrants exercisable for common stock, price per share					$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00		$ 1.00	$ 1.00
Expiration of warrants, years					1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year
Expiration of warrants, days after common stock is quoted on OTCBB					180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days
Initial Interest expense		283,844
Amortization expense		$ 214,963	$ 0	$ 433,871

XML

6. Derivative Liabilities (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Derivative liability	$ 440,494	$ 276,000
Level 1
Derivative liability	0	0
Level 2
Derivative liability	0	0
Level 3
Derivative liability	440,494	276,000
Fair Value
Derivative liability	$ 440,494	$ 276,000

XML

2. Inventories

9 Months Ended

Sep. 30, 2013

Inventory Disclosure [Abstract]

2. Inventories

2. Inventories

Inventories are stated at the lower of cost or market value. The Company reduces the value of its inventories to market value when the value is believed to be less than the cost of the item.

	September 30, 2013	December 31, 2012
Raw materials	$ -	$ -
Work-in-process	-	-
Finished goods	121,490	125,408
Total Inventories	$ 121,490	$ 125,408

No reserves for inventory have been deemed necessary at September 30, 2013.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	117,248,000	117,248,000
Common stock, shares outstanding	117,248,000	117,248,000
Discount on convertible debentures	$ 168,973	$ 134,292

XML

3. Machinery and Equipment (Tables)

9 Months Ended

Sep. 30, 2013

Property, Plant and Equipment [Abstract]

Machinery and equipment

	Estimated Useful Lives	September 30, 2013	December 31, 2012
Computer Equipment	3 Years	$ 4,162	$ 4,162
Machinery and equipment	5 Years	3,418	3,418
Furniture and fixtures	7 Years	14,073	14,073
Accumulated depreciation		(11,170)	(8,191)
		$ 10,483	$ 13,462

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 10, 2013
Document And Entity Information
Entity Registrant Name	Technology Applications International Corp
Entity Central Index Key	0001481427
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		117,348,000
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2013
Amendment Description	Amendment #1

XML

6. Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements

Derivative Liabilities

	Level 1	Level 2	Level 3	Fair Value at September 30, 2013
Liabilities
Derivative Liability	-	-	$     440,494	$          440,494

	Level 1	Level 2	Level 3	Fair Value at December 31, 2012
Liabilities
Derivative Liability	-	-	$     276,000	$          276,000

Derivative Liability Fair Value Adjustment

Balance as of December 31, 2011	$ -
Derivative liability recorded	353,200
Fair value adjustment	(77,200)
Balance at December 31, 2012	276,000
Derivative liability recorded	399,244
Fair value adjustment	(234,750)
Balance at September 30, 2013	$ 440,949

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended		47 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Income Statement [Abstract]
Revenues	$ 4,313	$ 1,837	$ 35,841	$ 3,287	$ 45,320
Cost of revenues	(1,219)	827	6,039	1,148	10,533
Gross profit	5,532	1,010	29,802	2,139	34,787
Expenses
General and administrative	77,635	165,045	365,336	563,294	1,303,370
Loss From Operation	(72,103)	(164,035)	(335,534)	(561,155)	(1,268,583)
Other income (expense)
Gain (loss) on derivative valuation	(8,250)	0	85,150	0	162,350
Interest expense	(74,050)	0	(231,581)	0	(465,095)
Total other income (expense)	(82,300)	0	(146,431)	0	(302,745)
Net loss	$ (154,403)	$ (164,035)	$ (481,965)	$ (561,155)	$ (1,571,328)
Loss per share
Basic and diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average number of shares
Basic and diluted	117,248,000	117,248,000	117,248,000	117,204,686

XML

7. Related Parties

9 Months Ended

Sep. 30, 2013

Related Party Transactions [Abstract]

Related Parties

7. Related Parties

An affiliate of the Company, an entity owned by the Company’s president, has been funding operations of the Company by making payments directly to third parties or advancing monies to the Company. These amounts bear no interest and are payable on demand. Amounts due to the affiliate at September 30, 2013 and 2012 are approximately $163,000 and $158,000, respectively.

During September 2012, the Company borrowed $125,000 from an affiliate. The loan bears interest at 10% per annum and is unsecured and payable upon demand. The Company has paid $47,600 towards the loan amount. The outstanding balance at September 30, 2013 and December 31, 2012 is $77,401 and $88,880, respectively.

XML

6. Fair Value Measurements

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements

6. Fair Value Measurements

6. Fair Value Measurements

On a recurring basis, we measure certain financial assets and liabilities based upon the fair value hierarchy. The following table presents information about the Company’s liabilities measured at fair value as of September 30, 2013 and December 31, 2012:

	Level 1	Level 2	Level 3	Fair Value at September 30, 2013
Liabilities
Derivative Liability	-	-	$     440,494	$          440,494

	Level 1	Level 2	Level 3	Fair Value at December 31, 2012
Liabilities
Derivative Liability	-	-	$     276,000	$          276,000

The fair value changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), relate solely to the derivative liability as follows:

Balance as of December 31, 2011	$ -
Derivative liability recorded	353,200
Fair value adjustment	(77,200)
Balance at December 31, 2012	276,000
Derivative liability recorded	399,244
Fair value adjustment	(234,750)
Balance at September 30, 2013	$ 440,949

XML

5. Capital Stock (Details Narrative) (USD $)	2 Months Ended		24 Months Ended
	Feb. 29, 2012	Dec. 31, 2011	Dec. 31, 2012	Sep. 30, 2013 Units	Sep. 25, 2013	Aug. 14, 2013	Jul. 29, 2013	Jun. 10, 2013	May 31, 2013	May 23, 2013	Feb. 13, 2013	Sep. 25, 2012	Mar. 22, 2012	Nov. 08, 2011	Oct. 28, 2011	Oct. 20, 2011	Aug. 26, 2010
Notes to Financial Statements
Common stock issued for cash, shares, duration	794,000	236,000
Common stock issued for cash, value, duration	$ 397,000	$ 118,000
Common stock issued for equipment, shares																	100,000
Common stock issued for debt, shares																101,800,000
Common stock issued for services, shares														5,591,000	5,727,000
Private placement units offered											3,000,000				10000
Shares per unit											1				1,000
Common stock price per share											$ 1.00				$ 0.50
Warrants per unit											1				1
Class A Warrants, shares per warrant											1				1,000
Exercise price per share in warrant											$ 1.50				$ 1.00
Expiration of warrants, years					1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year		1 year
Expiration of warrants, days after common stock is quoted on OTCBB					180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days		180 days
Number of untis sold in February 13, 2013 private offering				0
Number of warrant shares issued, shares			1,030,000
Number of warrant shares expired, shares				1,030,000

XML

2. Inventories (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]
Raw materials	$ 0	$ 0
Work-in-process	0	0
Finished goods	121,490	125,408
Total Inventories	$ 121,490	$ 125,408

XML

1. Nature of Operations and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements

Nature of Operations

Nature of Operations

Technology Applications International Corporation (formerly Raj Ventures, Inc.) (“Technology”) was incorporated on October 14, 2009 under the laws of Florida. Renuell Int’l, Inc. and NueEarth, Inc., Technology’s wholly owned subsidiaries and Technology, collectively, are referred to here-in as the “Company”, a development stage company. The Company is engaged in developing market entry technology products and services into early and mainstream technology products and services. Through our subsidiaries, we are focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of Technology Applications International Corporation and its wholly owned subsidiaries, Renuell Int’l, Inc. and NueEarth, Inc. All significant inter-company accounts and transactions have been eliminated in consolidation.

Basis of Presentation and Going Concern Considerations

Basis of Presentation and Going Concern Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2013.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

The accompanying financial statements have been presented on the basis that it is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs. The Company’s ability to continue as a going concern is highly dependent upon management’s ability to increase near-term operating cash flows and obtain additional working capital through the issuance of debt and or equity. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

These consolidated financial statements present the financial condition, and results of operations and cash flows of the operating companies.

Development Stage Risk

Development Stage Risk

Since its inception, the Company has been dependent upon the receipt of capital investment to fund its operating activities. In addition to the normal risks associated with a new business venture, there can be no assurance that the Company’s business plans will be successfully executed. The Company’s ability to execute its business plans is dependent on its ability to obtain additional debt and equity financing and achieving a profitable level of operations. There can be no assurance that sufficient financing will be obtained or that we will achieve a profitable level of operations.

The Company has minimal revenues generated from operations due to the sale of sample products. Accordingly, the Company’s activities have been accounted for as those of a “Development Stage Enterprise” as set forth in Accounting Standards Codification (“ASC”) 915 “Development Stage Entities”. Among the disclosures required are that the Company’s financial statements be identified as those of a development stage company and that the statements of operations, shareholders’ equity / (deficit) and cash flows disclose activity since the date of the Company’s inception.

XML

8. Significant Agreement

9 Months Ended

Sep. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

8. Significant Agreement

8. Significant Agreement

On September 30, 2013, the Company and its wholly-owned subsidiary Renuell Int’l, Inc., Florida corporations (the “Company”) entered into a partially exclusive Co-License Agreement (the “License Agreement”) by and amongst the National Aeronautics and Space Administration, an agency of the United States (“N.A.S.A.”) and the Administrators of the Tulane Educational Fund (“Tulane University”) for the use of U.S. Patent No. 6,730,498 B1, an invention entitled “Production of Functional Proteins: Balance of Shear Stress and Gravity,” which was issued on May 4, 2004 (the “Patent”). The company currently uses the Patent process to develop our anti-aging skin creams and shampoos. The License Agreement permits the Company to use the Patent as well as the name N.A.S.A., with its products, as per the terms of the License Agreement.

In consideration of the grant of the License Agreement, the Company will pay a 2% royalty to both N.A.S.A. and Tulane University on the gross sales of any royalty-base products, for a total of a 4% royalty. The License agreement further requires the Company to remit to N.A.S.A. and Tulane University a non-refundable license fee in the amount of Five Thousand Dollars ($5,000) each (for a total of $10,000) upon the execution of the License Agreement. The Company also agrees to pay N.A.S.A. and Tulane University a minimum royalty of Five Thousand Dollars ($5,000) each (for a total of $10,000), at the end of each accounting period (“Accounting Period”). The Accounting Period shall begin on the date of the License Agreement and end on December 31, the first Accounting Period payment will be prorated. Subsequent Accounting Periods begin on January 1, and end on December 31, of each calendar year.

The License Agreement requires that the Company achieve a practical application of the Patent within three months from the commencement date of the License Agreement. Once a practical application is achieved the term of the agreement shall be equal to the unexpired term of the last patent to be in effect of the patent(s) encompassed under the Patent. The Company further agrees that any products using the Patent process shall be substantially manufactured in the United States.

XML

9. Subsequent Events

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

9. Subsequent Events

9. Subsequent Events

Pursuant to Accounting Standards Codification 855-10, the Company has evaluated all events or transactions that have occurred from July 1, 2013 through the filing with the SEC.

On October 2, 2013, the holders of convertible notes converted a total of $50,000 of principal and interest into 100,000 shares of our common stock.

On October 4, 2013, the Company terminated its distribution agreement (“Distribution Agreement”) by and between the Company and Regenetech, Inc., a Texas corporation, pursuant to the termination clauses contained within the Distribution Agreement. Regenetech, Inc., was in a material breach of contract of the Distribution Agreement, because Regenetech, Inc., failed to upkeep its license requirements with N.A.S.A. and the Tulane University in order to maintain the license in good standing. Due to the material breach of contract by Regenetech, Inc., the termination of the Distribution Agreement does not contain any early termination penalties to the Company.

XML

2. Inventories (Tables)

9 Months Ended

Sep. 30, 2013

Inventory Disclosure [Abstract]

Inventories

	September 30, 2013	December 31, 2012
Raw materials	$ -	$ -
Work-in-process	-	-
Finished goods	121,490	125,408
Total Inventories	$ 121,490	$ 125,408

XML

3. Machinery and Equipment (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Jun. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 993	$ 1,020	$ 2,979	$ 3,061

XML

7. Related Parties (Details Narrative) (USD $)	1 Months Ended	9 Months Ended
	Jun. 30, 2012	Mar. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]
Due to affiliates			$ 163,000	$ 158,000
Loan from affiliate	125,000
Interest rate on loan from affiliate	10.00%
Repayments on loan from affiliate		47,600
Oustanding balance on loan from affiliate			$ 77,401	$ 88,880

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		47 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Cash flows from operating activities
Net loss	$ (481,965)	$ (561,155)	$ (1,571,328)
Adjustments to reconcile net income to net cash used in operating activities:
Imputed interest on beneficial conversion feature of warrants attached to convertible debenture	0	(38,382)	0
Loss (Gain) on derivative valuation	(85,150)	0	(162,350)
Amortization of discount on convertible debentures	214,963	0	433,871
Depreciation and amortization	3,060	3,136	11,372
Shares issued for cancellation of debt	0	0	101,800
Shares issued for services rendered	0	0	11,318
Change in current assets and current liabilities:
(Increase) in accounts receivable	0	(198)	0
(Increase) decrease in inventory	3,918	(190,324)	(121,490)
(Increase) decrease in deposits	(10,000)	0	(60,000)
(Increase) decrease in other current assets	1,905	(190)	(1,909)
Increase in accounts payable and accrued expenses	117,315	134,620	313,209
Increase (decrease) in other current liabilities	2,000	(387)	0
Net cash used in operating activities	(233,954)	(576,116)	(1,147,307)
Cash flows from investing activities
Purchase of equipment	0	0	(21,553)
Increase in trademarks	0	(470)	(2,170)
Net cash used in investing activities	0	(470)	(23,723)
Cash flows from financing activities
Proceeds from short-term advances	5,000	0	5,000
Advances from (to) affiliate, net	5,316	(90,450)	264,959
Proceeds from loan from affiliate	0	125,000	125,000
Repayment of loan from affiliate	(11,479)	(16,000)	(47,599)
Proceeds from issuance of convertible debenture	119,000	31,944	319,000
Proceeds from issuance of common stock	0	465,055	509,250
Net cash provided by financing activities	117,837	515,549	1,175,610
Net change in cash and cash equivalents	(117,837)	(515,549)	4,580
Cash and cash equivalents, beginning balance	120,697	174,363	0
Cash and cash equivalents, ending balance	4,580	113,326	4,580
Supplemental disclosure of cash flow information
Income taxes paid	0	0	0
Interest paid	0	0	0
Non-cash transactions affecting Operating, Investing and Financing activities
Deposit converted to convertible debenture	0	100,000	100,000
Issuance of common stock - shareholder note payable	0	0	101,800
Issuance of common stock for services	$ 0	$ 0	$ 11,318

XML

5. Capital Stock

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements

5. Capital Stock

5. Capital Stock

Common Stock

On August 26, 2010, the Company issued 100,000 shares of its common stock to purchase equipment.

On October 20, 2011, the Company issued 101,800,000 shares of its common stock as payment for cancellation of debt for part of the amount due to its related party.

On October 28, 2011, the Company issued 5,727,000 shares of its common stock to a consultant as payment for services rendered.

On November 8, 2011, the Company issued 5,591,000 shares of its common stock to a consultant as payment for services rendered.

During November and December 2011, the Company issued 236,000 shares of its common stock through a private placement to several investors for total cash consideration of $118,000.

During January and February 2012, the Company issued 794,000 shares of its common stock through a private placement for total cash consideration of $397,000.

Stock Purchase Warrants

In conjunction with the Private Placement Memorandum dated October 28, 2011, the Company is offering up to 10,000 Units. Each Unit consists of 1,000 shares of common stock priced at $0.50 per share and one Class A Warrant to purchase 1,000 shares of common stock with an exercise price of $1.00 per share. These warrants expire on the earlier of (i) 180 days after the common stock commences quotation on the OTC Bulletin Board or (ii) one year after the date of issuance.

Warrants to purchase up to 1,030,000 shares of common stock were issued in accordance with the Private Placement Memorandum stated above. As these warrants were issued as part of a unit sold, there has been no value assigned to them. As of September 30, 2013, each of these warrants has expired.

In conjunction with the Private Placement Memorandum dated February 13, 2013, the Company is offering up to 3,000,000 units. Each unit consists of 1 share of common stock priced at $1.00 and one Class A Warrant to purchase 1 share of common stock with an exercise price of $1.50 per share. These warrants expire on the earlier of (i) 180 days after the common stock commences quotation on the OTC Bulletin Board or (ii) one year after the date of issuance. No issuances have been sold from this offering as of September 30, 2013.

XML

8. Significant Agreement (Details Narrative) (USD $)	Sep. 30, 2013
Co-License Agreement on Patent
Royalty percent paid to NASA per the patent license	20.00%
Royalty percent paid to Tulane University per the patent license	20.00%
Total royalty due on patent license agreement	4.00%
Minimum royalty due to NASA per calendar year accounting period	$ 5,000
Minimum royalty due to Tulane University per calendar year accounting period	5,000
Total royalty due per calendar year accounting period	$ 10,000
Months to achieve practical application of patent required by license	3 months

XML

3. Machinery and Equipment (Details) (USD $)			12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2012 Computer Equipment	Dec. 31, 2012 Machinery and Equipment	Dec. 31, 2012 Furniture and Fixtures
Computer Equipment	$ 4,162	$ 4,162
Machinery and equipment	3,418	3,418
Furniture and fixtures	14,073	14,073
Accumulated depreciation	(11,170)	(8,191)
Machinery and equipment, net	$ 10,483	$ 13,462
Estimated useful lives			3 years	5 years	7 years